Valuation Inhalation Sciences Sweden AB
Stocks
ISAB
SE0009983893
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1850 SEK | 0.00% |
|
-14.35% | -95.74% |
| 29/07 | Inhalation Sciences secures financing of up to €0.4m | FW |
| 16/06 | Inhalation Sciences Secures SEK 0.4m Research Grant | FW |
Company Valuation: Inhalation Sciences Sweden AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 99.74 | 116 | 55.29 | 61.28 | 65.83 | 170 |
| Change | - | 16.34% | -52.35% | 10.84% | 7.43% | 158.23% |
| Enterprise Value (EV) 1 | 93.94 | 103.5 | 54.79 | 54.54 | 61.82 | 167.2 |
| Change | - | 10.17% | -47.06% | -0.44% | 13.35% | 170.37% |
| P/E | 10.1x | -6.24x | -4.54x | -11.2x | -12.8x | -12.4x |
| PBR | 9.52x | 5.9x | 7.32x | 4.73x | 8.43x | 23.4x |
| PEG | - | 0x | 0.1x | 0.2x | 2.3x | -4.22x |
| Capitalization / Revenue | 9.84x | 12.3x | 4.53x | 3.5x | 5.96x | 55.9x |
| EV / Revenue | 9.27x | 11x | 4.49x | 3.12x | 5.6x | 55x |
| EV / EBITDA | -11.1x | -6.34x | -4.65x | -15.3x | -12.5x | -16.6x |
| EV / EBIT | -10.7x | -6.25x | -4.56x | -14.5x | -12.2x | -16.5x |
| EV / FCF | -36.4x | -8.06x | -7.3x | -25.5x | -76.7x | -23.9x |
| FCF Yield | -2.75% | -12.4% | -13.7% | -3.92% | -1.3% | -4.18% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 1.14 | -1.635 | -1.07 | -0.36 | -0.34 | -0.35 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 10.14 | 9.422 | 12.19 | 17.5 | 11.05 | 3.041 |
| EBITDA 1 | -8.499 | -16.32 | -11.78 | -3.569 | -4.937 | -10.04 |
| EBIT 1 | -8.741 | -16.57 | -12.02 | -3.756 | -5.076 | -10.16 |
| Net income 1 | 9.875 | -16.61 | -12.12 | -4.744 | -5.147 | -10.16 |
| Net Debt 1 | -5.8 | -12.55 | -0.501 | -6.735 | -4.003 | -2.831 |
| Reference price 2 | 11.5500 | 10.2000 | 4.8600 | 4.0400 | 4.3400 | 4.3400 |
| Nbr of stocks (in thousands) | 8,635 | 11,376 | 11,376 | 15,168 | 15,168 | 39,168 |
| Announcement Date | 14/5/21 | 11/4/22 | 11/4/23 | 11/4/24 | 27/5/25 | 27/5/26 |
1SEK in Million2SEK
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 998K | |
| 28.12x | 5.03x | 19.27x | 0.33% | 214B | |
| 32.65x | 5.96x | 18.88x | 0.75% | 140B | |
| 40.41x | 10.49x | 23.2x | -.--% | 133B | |
| 18.24x | 3.77x | 12.23x | -.--% | 69.19B | |
| 35.4x | 7.12x | 22.51x | -.--% | 51.28B | |
| 19.93x | 2.32x | 11.58x | 2.59% | 50.43B | |
| 27.07x | 5.38x | 18.39x | 0.74% | 39.85B | |
| 49.91x | 6.6x | 19.26x | -.--% | 39.27B | |
| 21.07x | 5.55x | 14.25x | 1.09% | 32.32B | |
| Average | 30.31x | 5.80x | 17.73x | 0.61% | 76.89B | |
| Weighted average by Cap. | 30.89x | 6.11x | 18.70x | 0.48% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ISAB Stock
- Valuation Inhalation Sciences Sweden AB
Select your edition
All financial news and data tailored to specific country editions
